Mr Israel Bimpe, Director of Africa Go-To-Market, Zipline Israel Bimpe is Director of Africa Go-To-Market at Zipline, where he spearheads the expansion of Zipline's drone delivery services across the continent. He is on the Board of Directors for Irembo, whose pioneer product, IremboGov, is a government services platform in Rwanda. Israel previously served as President of the International Pharmaceutical Students Federation. Plenary: Zipline is a logistics company that delivers lifesaving medical supplies to hospitals and health clinics using autonomous unmanned aircraft systems (UAS) More than two billion people on Earth lack easy and reliable access to critical medical products because of last-mile transportation challenges. Each day, these communities struggle to manage scarce blood products, vaccines, and other vital medicines—frequently facing medical inventory stockouts exacerbated by a deficient national logistics infrastructure. Zipline's pharmacists-led success represents a much-needed paradigm shift on how we integrate advanced technology into pharmacy practice and health systems more broadly. |
|
Dr Joanna C Moullin, pharmacy practice lecturer and a leader in implementation science from Curtin University, WA, Australia. Plenary: Harnessing implementation science to walk the talk Implementation science has been embraced by funders, policymakers, and researchers alike, but is it really a silver bullet? This presentation will begin with a historical overview of implementation science and its application in social pharmacy. Dr Moullin will share examples of projects, her experiences with implementation, and directions for future work. |
|
Dr Faye McMillan, Associate Professor in Aboriginal and Torres Strait Islander Health, School of Population Health, University of New South Wales, Australia. Plenary: Coming of age 2022 marks 21 years since the first Aboriginal person became a registered pharmacist in Australia. 21 years, coming of age, what does it mean for the current pharmacy profession and what is the impact on the future pharmacy workforce. Using my own lived experiences of ‘othering’ to bring you on the journey of where we have been, where we are now and where we want to be in the future in building global capacity in a time of change. |
|
Professor Jon C Schommer, University of Minnesota, United States Plenary: The first 100 year of social pharmacy: We're half-way there This plenary presentation will outline the development of Social Pharmacy from 1970 to 2022 and show how this discipline is highly respected, productive and an integral part of translational research in pharmacy that spans (1) basic science research, (2) translation to humans, (3) translation to patients, (4) translation to practice, and (5) translation to communities. The integrated nature of research in pharmacy that spans from bench to bedside - to best practice -to best outcome - to best value, opens new opportunity for the Social Pharmacy discipline to further develop as an integrated and multi-faceted scientific domain. Over the past 50 years this discipline has positioned itself through an intentional outward focus that met individual, societal and professional needs. The focus was on the “other” instead of the “us.” It also created organization and structure by articulating a clear polity, developing places to meet, a healthy system of groups, defined leadership, processes and procedures. Members are being integrated into this healthy discipline on a continual basis. Social Pharmacy has reached a point where it is highly respected and productive. It would be tempting to become complacent and turn the previous stages of development into ends instead of means. Members could be tempted to hold onto the programs, processes, and styles where they are comfortable. It is proposed that now is a good time for our discipline to invest in rebirth through a renewed commitment to an intentional outward focus. Rebirth does not give up the strong foundations that are already in place. By rebirth, we mean that we are poised to take an intentional outward focus and discover what new opportunities lay before us. What does this look like? How are you contributing to such an outward focus? What are the next, great opportunities for us? During this session, audience members will be invited to tell their stories and share their ideas. |
|
Professor Claire Anderson, University of Nottingham, United Kingdom Plenary: A global vision for social pharmacy: building capacity in a time of change through integration, impact and influence The development of social pharmacy as a discipline has been internationally diverse and it has been defined in many ways. I will begin by addressing the question “What is social pharmacy?” by considering the environment in which it has developed and what we can learn for the future. I will then consider how we develop the field under a number of themes including working with others, patient and public involvement, impact and influence. I will then examine the future of social pharmacy and discuss the importance research and academic capacity building, Finally, I will provide some thoughts on how social pharmacy might continue to develop given the global challenges we face including; pandemics, climate change ,security, migration, global inequalities in access to medicines, workforce issues, shifting modes of delivery of healthcare, increasing use of technology, AI and the various agendas for medicines’ design and development.
|